Mishra Anjali, Pradhan Prasanta Kumar, Gambhir Sanjay, Sabaretnam Myilvaganan, Gupta Archana, Babu Satish
Department of Endocrine Surgery, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
Department of Nuclear Medicine, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India.
J Surg Res. 2015 Feb;193(2):731-7. doi: 10.1016/j.jss.2014.07.065. Epub 2014 Aug 12.
There is concern about potential interference of iodinated contrast used in contrast-enhanced computerized tomography (CECT) with radioiodine therapy in differentiated thyroid carcinoma (DTC). The aim of this study was to determine the effect of iodinated contrast on urinary iodine concentration (UIC) in patients having thyroidectomy compared with control groups without CECT and without thyroidectomy.
This prospective control study consisted of 4 groups each comprising 32 patients. Group 1- DTC patients undergoing preoperative CECT, group 2- DTC patients not undergoing CECT, group 3- benign goiter patients undergoing preoperative CECT, and group 4- patients with non-thyroidal diseases undergoing preoperative CECT. Spot UIC before CECT, after surgery (5-7 d), and at follow-up (4-6 wk) were compared among the groups.
The median basal UIC levels were not significantly different between the four groups (232.2 versus 263.9 versus 268.2 versus 178.2 μg/L, respectively, P = 0.443). In contrast, groups having preoperative CECT had significantly higher UIC levels at discharge (924 versus 329 versus 776 versus 661 μg/L, respectively, P = 0.001). These differences became insignificant at follow-up (225 versus 252 versus 310 versus 275 μg/L, respectively, P = 0.505). Patients having follow-up UIC values above the conventional cut-off of clinically relevant iodine excess (>200 μg/L) also had significantly higher basal values than those having lower follow-up values (283.0 versus 181.7 μg/L; P = 0.037).
Irrespective of the fact whether a patient is thyroidectomized or not preoperative CECT using non-lipophilic contrast does not result in long-term iodine retention.
人们担心在分化型甲状腺癌(DTC)中,增强计算机断层扫描(CECT)中使用的碘化造影剂可能会干扰放射性碘治疗。本研究的目的是确定与未进行CECT且未进行甲状腺切除术的对照组相比,碘化造影剂对甲状腺切除术后患者尿碘浓度(UIC)的影响。
这项前瞻性对照研究包括4组,每组32例患者。第1组为接受术前CECT的DTC患者,第2组为未接受CECT的DTC患者,第3组为接受术前CECT的良性甲状腺肿患者,第4组为接受术前CECT的非甲状腺疾病患者。比较各组在CECT前、术后(5 - 7天)和随访时(4 - 6周)的即时UIC。
四组的中位基础UIC水平无显著差异(分别为232.2、263.9、268.2和178.2μg/L,P = 0.443)。相比之下,接受术前CECT的组在出院时的UIC水平显著更高(分别为924、329、776和661μg/L,P = 0.001)。这些差异在随访时变得不显著(分别为225、252、310和275μg/L,P = 0.505)。随访时UIC值高于临床相关碘过量的传统临界值(>200μg/L)的患者,其基础值也显著高于随访值较低的患者(283.0对181.7μg/L;P = 0.037)。
无论患者是否接受甲状腺切除术,使用非亲脂性造影剂的术前CECT不会导致长期碘潴留。